Penserra Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$287K Buy
373
+120
+47% +$91.9K ﹤0.01% 604
2025
Q4
$194K Sell
253
-107
-30% -$72.7K ﹤0.01% 678
2025
Q3
$202K Sell
360
-42
-10% -$23.7K ﹤0.01% 706
2025
Q2
$210K Buy
402
+393
+4,367% +$219K ﹤0.01% 643
2025
Q1
$5K Sell
9
-267
-97% -$184K ﹤0.01% 925
2024
Q4
$196K Buy
276
+267
+2,967% +$224K ﹤0.01% 747
2024
Q3
$9K Hold
9
﹤0.01% 897
2024
Q2
$9K Hold
9
﹤0.01% 939
2024
Q1
$8K Sell
9
-487
-98% -$463K ﹤0.01% 941
2023
Q4
$434K Sell
496
-138
-22% -$114K 0.01% 559
2023
Q3
$520K Sell
634
-110
-15% -$86.5K 0.01% 495
2023
Q2
$533K Buy
744
+688
+1,229% +$530K 0.01% 503
2023
Q1
$45K Hold
56
﹤0.01% 860
2022
Q4
$40K Sell
56
-46
-45% -$33.9K ﹤0.01% 917
2022
Q3
$70K Buy
102
+86
+538% +$54.1K ﹤0.01% 776
2022
Q2
$9K Sell
16
-8,466
-100% -$5.5M ﹤0.01% 1283
2022
Q1
$5.92M Buy
8,482
+4,800
+130% +$3.04M 0.14% 183
2021
Q4
$2.33M Buy
+3,682
New +$2.26M 0.05% 343
2020
Q3
Sell
-1,690
Closed -$1.05M 1020
2020
Q2
$1.05M Sell
1,690
-12,442
-88% -$7.06M 0.05% 254
2020
Q1
$6.9M Buy
+14,132
New +$5.83M 0.47% 65
2019
Q1
Sell
-8,948
Closed -$3.34M 786
2018
Q4
$3.34M Buy
+8,948
New +$3.28M 0.32% 83
2017
Q3
Sell
-867
Closed -$425K 590
2017
Q2
$425K Buy
+867
New +$379K 0.15% 112
2017
Q1
Sell
-49
Closed -$17K 779
2016
Q4
$17K Buy
49
+8
+20% +$3.04K ﹤0.01% 704
2016
Q3
$16K Buy
41
+16
+64% +$6.42K ﹤0.01% 681
2016
Q2
$9K Buy
25
+10
+67% +$3.85K ﹤0.01% 749
2016
Q1
$5 Sell
15
-1,163
-99% -$479K ﹤0.01% 849
2015
Q4
$639K Buy
+1,178
New +$638K 0.06% 111

Other funds holding REGN